Breast cancer (Tokyo, Japan)

Keyphrases

Publications

volume 31, number 4, 2024

Yuhang Shang, Xuelian Wang, Yansong Liu, Weilun Cheng, Yunqiang Duan, Zhengbo Fang, Jiangwei Liu, Fanjing Kong, Ting Wang, Tianshui Yu, Anbang Hu, Jiarui Zhang, Hanyu Zhang, Mingcui Li, Zhiyuan Rong, Yanling Li, Suborna S Shakila, Xinxin Li, Jianyuan Feng, Fei Ma, Baoliang Guo
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Katsuyoshi Suzuki, Shinichiro Morishita, Jiro Nakano, Taro Okayama, Junichiro Inoue, Takashi Tanaka, Takuya Fukushima
Association between quality of life and mortality risk in patients with breast cancer: a systematic review and meta-analysis. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Sei Na, Milim Kim, Yujun Park, Hyun Jung Kwon, Hee-Chul Shin, Eun-Kyu Kim, Mijung Jang, Sun Mi Kim, So Yeon Park
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Yan Chen, Yuxin Zhou, Jiafeng Chen, Jiahui Yang, Yijie Yuan, Weizhu Wu
Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Karla C Maita, Francisco R Avila, Ricardo A Torres-Guzman, John P Garcia, Gioacchino D De Sario Velasquez, Sahar Borna, Sally A Brown, Clifton R Haider, Olivia S Ho, Antonio Jorge Forte
The usefulness of artificial intelligence in breast reconstruction: a systematic review. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Yong-Qiang Bao, Teng-Hua Yu, Wei Huang, Qing-Feng Mao, Gan-Jie Tu, Bin Li, An Yi, Jin-Gao Li, Jun Rao, Huai-Wen Zhang, Chun-Ling Jiang
Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Yuhang Shang, Xuelian Wang, Yansong Liu, Weilun Cheng, Yunqiang Duan, Zhengbo Fang, Jiangwei Liu, Fanjing Kong, Ting Wang, Tianshui Yu, Anbang Hu, Jiarui Zhang, Hanyu Zhang, Mingcui Li, Zhiyuan Rong, Yanling Li, Suborna S Shakila, Xinxin Li, Jianyuan Feng, Fei Ma, Baoliang Guo
Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Hisanori Kawamoto, Koichiro Tsugawa, Yuko Furuya, Kaori Sakamaki, Sayoko Kakimoto, Mina Kitajima, Mariko Nagai Takishita, Mizuho Tazo, Mari Hara Nakano, Takako Kuroda, Ayaka Shimo, Arata Shimo, Yasuyuki Kojima, Makiko Tsuzuki, Ai Motoyoshi, Ei Haku, Toru Nishikawa, Yoshihide Kanemaki, Hidefumi Mimura, Mamoru Fukuda
Percutaneous ultrasound-guided cryoablation for early-stage primary breast cancer: a follow-up study in Japan. Breast cancer (Tokyo, Japan) 31 (4) (2024)

volume 31, number 5, 2024

Songul Duran, Umut Varol, Özlem Tekir, Ahmet Hakan Soytürk
Resilience's impact on quality of life and post-traumatic growth in breast cancer patients during treatment. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Shinsuke Sasada, Hiraku Kumamaru, Naoki Hayashi, Naoko Kinukawa, Masakazu Toi, Hiromitsu Jinno, Shigehira Saji
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Jiao-Fei Wei, Fan Li, Jia-Wen Lin, Zi-Ang Dou, Shu-Qin Li, Jun Shen
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Mari Hosonaga, Eri Habano, Hiromi Arakawa, Keika Kaneko, Takeshi Nakajima, Naomi Hayashi, Ippei Fukada, Akira Nakamura, Yurie Haruyama, Tetsuyo Maeda, Hitoshi Inari, Takayuki Kobayashi, Eri Nakashima, Takayuki Ueno, Toshimi Takano, Shunji Takahashi, Shinji Ohno, Arisa Ueki
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers. Breast cancer (Tokyo, Japan) 31 (5) (2024)
E Mur-Gimeno, M Coll, A Yuguero-Ortiz, M Navarro, M Vernet-Tomás, A Noguera-Llauradó, Sebio-García Raquel
Comparison of water- vs. land-based exercise for improving functional capacity and quality of life in patients living with and beyond breast cancer (the AQUA-FiT study): a randomized controlled trial. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Lida A Mina, Raymond Brig, Michael Danso, Yuan Yuan, William F Symmans, Julia F Hopkins, Lee A Albacker, Antonello Abbattista, Kay Noonan, Marielena Mata, A Douglas Laird, Joanne L Blum
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Songul Duran, Umut Varol, Özlem Tekir, Ahmet Hakan Soytürk
Resilience's impact on quality of life and post-traumatic growth in breast cancer patients during treatment. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Yu-An Chen, Hsuan-Wen Lai, Hui-Chen Su, El-Wui Loh, Tsai-Wei Huang, Ka-Wai Tam
Efficacy and safety of adjuvant therapies in older patients with breast cancer: a systematic review and meta-analysis of real-world data. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Sae Kitano, Ryo Tsunashima, Chikage Kato, Akira Watanabe, Yoshiaki Sota, Saya Matsumoto, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Sujata Purja, Dung Thuy Nguyen, Eun Young Kim
Breast cancer epigenetics: current and evolving treatment. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Lida A Mina, Raymond Brig, Michael Danso, Yuan Yuan, William F Symmans, Julia F Hopkins, Lee A Albacker, Antonello Abbattista, Kay Noonan, Marielena Mata, A Douglas Laird, Joanne L Blum
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Beatriz Tinoco Franceschi, Patrícia Heloise Alves Bezerra, Maria Regina Torqueti
Antitumor effects of co-treatment of resveratrol with antitumor drugs in ER- and HER2-positive breast cancer cells are due to induction of apoptosis and modulation of estrogen receptor expression. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Yaping Huang, Chengjie Ke, Jiaqin Cai, Xiaoxia Wei, Maohua Chen, Hong Sun
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Toshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, Naoki Niikura, Yeon Hee Park, Keun Seok Lee, Yee Soo Chae, Binghe Xu, Xiaojia Wang, Seock-Ah Im, Wei Li, Yen-Shen Lu, Cecilia Orbegoso Aguilar, Soichiro Nishijima, Yuji Nishiyama, Masahiro Sugihara, Shanu Modi, Junji Tsurutani
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Pinelli Fulvio, Francesco Barbani, Barbara Defilippo, Angela Fundarò, Alessandra Nella, Valentina Selmi, Stefano Romagnoli, Gianluca Villa
Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Toshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, Naoki Niikura, Yeon Hee Park, Keun Seok Lee, Yee Soo Chae, Binghe Xu, Xiaojia Wang, Seock-Ah Im, Wei Li, Yen-Shen Lu, Cecilia Orbegoso Aguilar, Soichiro Nishijima, Yuji Nishiyama, Masahiro Sugihara, Shanu Modi, Junji Tsurutani
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Melinda L Telli, Jennifer K Litton, J Thaddeus Beck, Jason M Jones, Jay Andersen, Lida A Mina, Raymond Brig, Michael Danso, Yuan Yuan, William F Symmans, Julia F Hopkins, Lee A Albacker, Antonello Abbattista, Kay Noonan, Marielena Mata, A Douglas Laird, Joanne L Blum
Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Shogo Nakamoto, Takayuki Iwamoto, Naruto Taira, Yukiko Kajiwara, Kengo Kawada, Daisuke Takabatake, Yuichiro Miyoshi, Shinichiro Kubo, Yoko Suzuki, Mari Yamamoto, Yutaka Ogasawara, Minami Hatono, Seiji Yoshitomi, Kyoko Hara, Asako Sasahara, Shozo Ohsumi, Masahiko Ikeda, Hiroyoshi Doihara, Yuri Mizota, Seiichiro Yamamoto, Tadahiko Shien, Shinichi Toyooka
The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Pinelli Fulvio, Francesco Barbani, Barbara Defilippo, Angela Fundarò, Alessandra Nella, Valentina Selmi, Stefano Romagnoli, Gianluca Villa
Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Kimie Miyazawa, Toshihiko Satake, Mayu Muto, Yui Tsunoda, Tomoyuki Koike, Kazutaka Narui, Ryohei Katsuragi, Satoshi Onoda, Takashi Ishikawa
Delayed breast reconstruction with autologous free flap after radiation therapy: vascular complications and aesthetic outcomes. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Toshinari Yamashita, Joo Hyuk Sohn, Eriko Tokunaga, Naoki Niikura, Yeon Hee Park, Keun Seok Lee, Yee Soo Chae, Binghe Xu, Xiaojia Wang, Seock-Ah Im, Wei Li, Yen-Shen Lu, Cecilia Orbegoso Aguilar, Soichiro Nishijima, Yuji Nishiyama, Masahiro Sugihara, Shanu Modi, Junji Tsurutani
Trastuzumab deruxtecan versus treatment of physician's choice in previously treated Asian patients with HER2-low unresectable/metastatic breast cancer: subgroup analysis of the DESTINY-Breast04 study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Chiara Bellini, Francesca Pugliese, Giulia Bicchierai, Francesco Amato, Diego De Benedetto, Federica Di Naro, Cecilia Boeri, Ermanno Vanzi, Giuliano Migliaro, Ludovica Incardona, Cinzia Tommasi, Lorenzo Orzalesi, Vittorio Miele, Jacopo Nori
Contrast-enhanced mammography in the management of breast architectural distortions and avoidance of unnecessary biopsies. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Hirohito Seki, Akiko Ogiya, Naomi Nagura, Ayaka Shimo, Kazutaka Narui, Shinsuke Sasada, Makoto Ishitobi, Hiroko Nogi, Naoto Kondo, Teruhisa Sakurai, Chikako Yamauchi, Hiroki Mori, Miho Saiga, Naoki Niikura, Tadahiko Shien, null null
Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Monika Kataria, Nishkarsh Gupta, Aasheesh Kumar, Sandeep Kumar Bhoriwal, Akanksha Singh, Varun Shekhar, Rohit Bhatia
Assessing the effectiveness of high frequency repetitive transcranial magnetic stimulation for post-mastectomy pain in breast cancer patients: A randomized controlled trial. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Hiromi Okuyama, Fuka Takada, Naruto Taira, Seigo Nakamura
A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Mari Hosonaga, Eri Habano, Hiromi Arakawa, Keika Kaneko, Takeshi Nakajima, Naomi Hayashi, Ippei Fukada, Akira Nakamura, Yurie Haruyama, Tetsuyo Maeda, Hitoshi Inari, Takayuki Kobayashi, Eri Nakashima, Takayuki Ueno, Toshimi Takano, Shunji Takahashi, Shinji Ohno, Arisa Ueki
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Kadri Altundag
Not all patients with premenopausal breast cancer will experience the negative effects of tamoxifen treatment on their bone mineral density. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Yunbo Luo, Xiaomei Chen, Ruibo Lv, Qingyun Li, Shuangqiang Qian, Xia Xu, Lingmi Hou, Wei Deng
Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Hirohito Seki, Akiko Ogiya, Naomi Nagura, Ayaka Shimo, Kazutaka Narui, Shinsuke Sasada, Makoto Ishitobi, Hiroko Nogi, Naoto Kondo, Teruhisa Sakurai, Chikako Yamauchi, Hiroki Mori, Miho Saiga, Naoki Niikura, Tadahiko Shien, null null
Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: a retrospective multi‑institutional study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Mari Hosonaga, Eri Habano, Hiromi Arakawa, Keika Kaneko, Takeshi Nakajima, Naomi Hayashi, Ippei Fukada, Akira Nakamura, Yurie Haruyama, Tetsuyo Maeda, Hitoshi Inari, Takayuki Kobayashi, Eri Nakashima, Takayuki Ueno, Toshimi Takano, Shunji Takahashi, Shinji Ohno, Arisa Ueki
Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Shinsuke Sasada, Hiraku Kumamaru, Naoki Hayashi, Naoko Kinukawa, Masakazu Toi, Hiromitsu Jinno, Shigehira Saji
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Jiao-Fei Wei, Fan Li, Jia-Wen Lin, Zi-Ang Dou, Shu-Qin Li, Jun Shen
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Lizhi Teng, Juntong Du, Shuai Yan, Peng Xu, Jiangnan Liu, Xinyang Zhao, Weiyang Tao
A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Pinelli Fulvio, Francesco Barbani, Barbara Defilippo, Angela Fundarò, Alessandra Nella, Valentina Selmi, Stefano Romagnoli, Gianluca Villa
Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Shinsuke Sasada, Hiraku Kumamaru, Naoki Hayashi, Naoko Kinukawa, Masakazu Toi, Hiromitsu Jinno, Shigehira Saji
Impact of immediate breast reconstruction on perioperative therapy: insights from a Japanese Nationwide Registry. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Jiao-Fei Wei, Fan Li, Jia-Wen Lin, Zi-Ang Dou, Shu-Qin Li, Jun Shen
Development and validation of a neoadjuvant chemotherapy pathological complete remission model based on Reg IV expression in breast cancer tissues: a clinical retrospective study. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Lizhi Teng, Juntong Du, Shuai Yan, Peng Xu, Jiangnan Liu, Xinyang Zhao, Weiyang Tao
A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Baona Wang, Huaqing Chu, Shijing Wei, Huan Hsu, Jiao Geng, Mengyuan Xu, Xin Zhang, Jie Yu, Hui Zheng
Exploration of treatment strategies and susceptibility gene of postoperative nausea and vomiting in breast cancer patients: a randomised controlled trial. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Lizhi Teng, Juntong Du, Shuai Yan, Peng Xu, Jiangnan Liu, Xinyang Zhao, Weiyang Tao
A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Pascal Jézéquel, Hamza Lasla, Wilfried Gouraud, Agnès Basseville, Bertrand Michel, Jean-Sébastien Frenel, Philippe P Juin, Fadoua Ben Azzouz, Mario Campone
Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Songul Duran, Umut Varol, Özlem Tekir, Ahmet Hakan Soytürk
Resilience's impact on quality of life and post-traumatic growth in breast cancer patients during treatment. Breast cancer (Tokyo, Japan) 31 (5) (2024)